Simulations Plus (SLP) Prelim. Q4, FY16 Revenue Light of Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2016
September 12, 2016 8:30 AM EDTCompany Reports Record Fourth-Quarter and Full-Year Revenues
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fiscal fourth quarter (4QFY16) and full fiscal year 2016 (FY2016) ended August 31, 2016.
Mr. John R. Kneisel, chief financial officer of Simulations Plus, stated: We have completed our second year of operations following our September 2014 acquisition of Cognigen Corporation; an acquisition which delivered the expected benefits such as expanded addressable market, synergies across our software and... More
